Osteoporosis
Conditions
Brief summary
The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.
Interventions
BEHAVIORALDisease Management Assessment
Sponsors
Merck Sharp & Dohme LLC
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
65 Years to 89 Years
Healthy volunteers
No
Inclusion criteria
* Members of the Henry Ford Health System
Exclusion criteria
* Individuals who are not members of the Henry Ford Health System
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density (BMD) testing rates | — |
Secondary
| Measure | Time frame |
|---|---|
| Osteoporosis medication treatment rates | — |
Outcome results
None listed